The pharmacokinetics of methanol in the presence of ethanol: A case study

Clinical Pharmacokinetics

Volumn 50, Issue 4, 2011, Pages 245-251

  Coulter, Carolyn V ^a   Isbister, Geoffrey K ^b,c   Duffull, Stephen B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Alcohol, pharmacokinetics; Dose prediction; Haemofiltration; Methanol poisoning; Methyl alcohol, pharmacokinetics; Pharmacokinetic modelling

Indexed keywords

ALCOHOL; FOLIC ACID; METHANOL; THIAMINE;

ADULT; ALCOHOL INTOXICATION; ALCOHOLISM; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CASE REPORT; COMPUTER SIMULATION; CONTINUOUS HEMODIAFILTRATION; DATA ANALYSIS SOFTWARE; DIALYSATE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG INFUSION; DRUG METABOLISM; DRUG OVERDOSE; DRUG URINE LEVEL; ENZYME ASSAY; GAS CHROMATOGRAPHY; GLASGOW COMA SCALE; HUMAN; INGESTION; INTUBATION; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; METHANOL POISONING; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION;

ADULT; ALCOHOLISM; ANTIDOTES; COMPUTER SIMULATION; DIALYSIS SOLUTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG MONITORING; ETHANOL; HEMODIAFILTRATION; HUMANS; MALE; METABOLIC CLEARANCE RATE; METHANOL; MODELS, BIOLOGICAL; SOLVENTS;

EID: 79952056743     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11584250-000000000-00000     Document Type: Article

References (27)

1. Kostic MA, Dart RC. Rethinking the toxic methanol level. J Toxicol Clin Toxicol 2003; 41 (6): 793-800 (Pubitemid 37499007)
2. Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35 (2): 127-44
3. Lobert S. Ethanol, isopropanol, methanol, and ethylene glycol poisoning. Crit Care Nurse 2000; 20 (6): 41-7
4. Hovda KE, Hunderi OH, Tafjord A-B, et al. Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs. J InternMed 2005; 258: 181-90
5. Roe O. Species differences in methanol poisoning. Cri Rev Toxicol 1982; 10: 275-86 (Pubitemid 13181644)
6. Ekins BR, Rollins DE, Duffy DP, et al. Standardized treatment of severe methanol poisoning with ethanol and hemodialysis. West J Med 1985; 142 (3): 337-40 (Pubitemid 15091362)
7. Lushine KA, Harris CR, Holger JS. Methanol ingestion: prevention of toxic sequelae after massive ingestion. J Emerg Med 2003; 24 (4): 433-6 (Pubitemid 36555567)
8. Meyer RJ, Beard MEJ, Ardagh MW, et al. Methanol poisoning. N Z Med J 2000; 113: 11-3 (Pubitemid 30074291)
9. Hantson P, Haufroid V, Wallemacq P. Formate kinetics in methanol poisoning. Hum Exp Toxicol 2005; 24: 55-9 (Pubitemid 40523963)
10. McMartin KE, Ambre JJ, Tephly TR. Methanol poisoning in human subjects. Am J Med 1980; 68: 414-8
11. Jacobsen D, McMartin K. Methanol and formaldehyde poisoning. In: Brent J, Wallace K, Burkhart K, et al., editors. Critical care toxiology. Philadelphia (PA): Elsevier Mosby, 2005
12. Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344 (6): 424-9 (Pubitemid 32128675)
13. Casavant MJ. Fomepizole in the treatment of poisoning. Pediatrics 2001; 107: 170-1 (Pubitemid 32055431)
14. Druteika DP, Zed PJ, Ensom MHH. Role of fomepizole in the management of ethylene glycol toxicity: treatment. Pharmacotherapy 2002; 22 (3): 365-72 (Pubitemid 34205172)
15. Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Clin Toxicol 2002; 40 (4): 415-46 (Pubitemid 34976720)
16. Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 2009; 360: 2216-23
17. Norberg A, Jones WA, Hahn R, et al. Role of variability in explaining ethanol pharmacokinetics. Clin Pharmacokinet 2003; 42 (1): 1-3
18. Kan G, Jenkins I, Rangan G, et al. Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 2003; 18: 2665-7 (Pubitemid 37483806)
19. Sivilotti MLA, Burns MJ, Aaron CK. Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole. Clin Tox 2001; 39 (6): 627-31 (Pubitemid 33117063)
20. Megarbane B, Borron SW, Baud F. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 2005; 31:189-95 (Pubitemid 40362266)
21. Bestic M, Blackford M, Reed M. Fomepizole: a critical assessment of current dosing regimens. J Clin Pharmacol 2009; 49: 130-7
22. Holford N. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet 1987; 13 (5): 273-92 (Pubitemid 17161177)
23. Corley RA, Bartels MJ, Carney EW, et al. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic acid, in rats and humans. Toxicol Sci 2005; 85 (1): 476-90 (Pubitemid 40614277)
24. Haffner H-T, Wehner H-D, Scheytt K-D, et al. The elimination kinetics of methanol and the influence of ethanol. Int Legal Med 1992; 105 (2): 111-4
25. Graw M, Haffner H-T, Althaus L, et al. Invasion and distribution of methanol. Arch Toxicol 2000; 74 (6): 313-21 (Pubitemid 30660934)
26. Dawidek-Pietryka K, Szczepaniak S, Dudka J, et al. In vitro studies of human alcohol dehydrogenase inhibition in the process of methanol and ethylene glycol oxidation. Arch Toxicol 1998; 72: 604-7
27. Wagner FW, Burger AR, Vallee BL. Kinetic properties of human liver alcohol dehydrogenase: oxidation of alcohols by class I isoenzymes. Biochemistry 1983; 22 (8): 1857-63 (Pubitemid 13093452)